
What We’re Reading: H5N1 Vaccine Plan; Long-Acting Insulin Safety Risk; LA County's Plan to Tackle Medical Debt
HHS officials are moving forward with a plan to produce 4.8 million doses of H5N1 avian flu vaccine; Novo Nordisk’s long-acting insulin had a greater risk of excessively lowering patients’ blood sugar without offering better sugar level management; Los Angeles County launched an ambitious effort to tackle medical debt.
HHS Advances H5N1 Vaccine Plan
HHS officials are moving forward with a plan to produce 4.8 million doses of H5N1 avian flu vaccine for pandemic preparedness, according to
Safety Concerns Raised for Novo Nordisk’s Long-Acting Insulin
FDA staff found that Novo Nordisk’s long-acting insulin had a greater risk of excessively lowering patients’ blood sugar without offering better management of sugar levels or other benefits, according to
LA County Launches Plan to Tackle Medical Debt
Los Angeles (LA) County recently launched an ambitious effort to tackle medical debt, targeting hospitals for their role in the $2.9 billion problem, according to
Related to this article








